Trial Profile
Repeated Injection of GnRH Agonist for Triggering Final Oocyte Maturation in Patients at High Risk of Ovarian Hyperstimulation Syndrome in GnRH Antagonist Protocol
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 Jun 2023
Price :
$35
*
At a glance
- Drugs Triptorelin (Primary)
- Indications Ovarian hyperstimulation syndrome
- Focus Therapeutic Use
- 13 Jan 2014 New trial record